Topic List : Cancer
‘Cascade’ testing identifies relatives at risk
An online effort coupled with lower costs significantly increased the proportion of cancer patients’ relatives who chose to undergo genetic testing for cancer-associated mutations in Stanford study.
Test predicts lymphoma therapy success
Changes in circulating tumor DNA levels quickly predict how patients with diffuse large B cell lymphoma are responding to therapy, according to a Stanford-led study. Currently, patients wait months for the results.
Common skin cancer linked to other cancers
Frequent skin cancers due to mutations in genes responsible for repairing DNA are linked to a threefold risk of unrelated cancers, according to a Stanford study. The finding could help identify people for more vigilant screening.
How a magnetized wire attracts tumor cells
Scientists at Stanford used the wire to capture free-floating tumor cells in the blood, a technique that soon could be used in humans to yield an earlier cancer diagnosis.
D-limonene could offset dry mouth in cancer patients
A Stanford collaboration between clinical and basic science researchers has led to the identification of a compound that could improve the quality of life for head and neck cancer patients.
PET tracer predicts success of cancer ‘vaccine’
With a radioactive tracer, scientists can use a PET scan to quickly tell whether a cancer immunotherapy will be effective or not, according to a new Stanford study.
Multigene tests for breast cancer on the rise
Tests to detect mutations in multiple genes are replacing BRCA-only analyses in women with breast cancer, according to a study by scientists at Stanford and several other institutions. Greater access to genetic counselors needed.
For ‘Project Lung,’ research gets personal
When James Spudich was diagnosed with lung cancer, researchers had a rare, and unexpected, opportunity to study healthy and diseased human tissue at an unprecedented level of detail.
Henrietta Lacks family members speak
Grandchildren of Henrietta Lacks, whose tissue sample became the source of the first immortalized cell line, spoke at an event featuring Rebecca Skloot, author of The Immortal Life of Henrietta Lacks.
$11.9 million for anti-leukemia trial
The California Institute for Regenerative Medicine awarded Stanford researcher Crystal Mackall a grant to study immune cells genetically modified to attack two proteins on leukemia and lymphoma cells.